Literature DB >> 23184638

Promise of personalized omics to precision medicine.

Rui Chen1, Michael Snyder.   

Abstract

The rapid development of high-throughput technologies and computational frameworks enables the examination of biological systems in unprecedented detail. The ability to study biological phenomena at omics levels in turn is expected to lead to significant advances in personalized and precision medicine. Patients can be treated according to their own molecular characteristics. Individual omes as well as the integrated profiles of multiple omes, such as the genome, the epigenome, the transcriptome, the proteome, the metabolome, the antibodyome, and other omics information are expected to be valuable for health monitoring, preventative measures, and precision medicine. Moreover, omics technologies have the potential to transform medicine from traditional symptom-oriented diagnosis and treatment of diseases toward disease prevention and early diagnostics. We discuss here the advances and challenges in systems biology-powered personalized medicine at its current stage, as well as a prospective view of future personalized health care at the end of this review.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23184638      PMCID: PMC4154620          DOI: 10.1002/wsbm.1198

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Syst Biol Med        ISSN: 1939-005X


  83 in total

Review 1.  Rep-Seq: uncovering the immunological repertoire through next-generation sequencing.

Authors:  Jennifer Benichou; Rotem Ben-Hamo; Yoram Louzoun; Sol Efroni
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

Review 2.  Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?

Authors:  Jan van der Greef; Thomas Hankemeier; Robert N McBurney
Journal:  Pharmacogenomics       Date:  2006-10       Impact factor: 2.533

3.  The human disease network.

Authors:  Kwang-Il Goh; Michael E Cusick; David Valle; Barton Childs; Marc Vidal; Albert-László Barabási
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

Review 4.  Boosting signal-to-noise in complex biology: prior knowledge is power.

Authors:  Trey Ideker; Janusz Dutkowski; Leroy Hood
Journal:  Cell       Date:  2011-03-18       Impact factor: 41.582

Review 5.  Extracellular microRNA: a new source of biomarkers.

Authors:  Alton Etheridge; Inyoul Lee; Leroy Hood; David Galas; Kai Wang
Journal:  Mutat Res       Date:  2011-03-23       Impact factor: 2.433

6.  Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.

Authors:  Keiichi Kodama; Momoko Horikoshi; Kyoko Toda; Satoru Yamada; Kazuo Hara; Junichiro Irie; Marina Sirota; Alexander A Morgan; Rong Chen; Hiroshi Ohtsu; Shiro Maeda; Takashi Kadowaki; Atul J Butte
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-12       Impact factor: 11.205

7.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

Review 8.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

9.  Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases.

Authors:  Rong Chen; Erik Corona; Martin Sikora; Joel T Dudley; Alex A Morgan; Andres Moreno-Estrada; Geoffrey B Nilsen; David Ruau; Stephen E Lincoln; Carlos D Bustamante; Atul J Butte
Journal:  PLoS Genet       Date:  2012-04-12       Impact factor: 5.917

10.  A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers.

Authors:  Rachael Natrajan; Alan Mackay; Maryou B Lambros; Britta Weigelt; Paul M Wilkerson; Elodie Manie; Anita Grigoriadis; Roger A'Hern; Petra van der Groep; Iwanka Kozarewa; Tatiana Popova; Odette Mariani; Samra Turaljic; Simon J Furney; Richard Marais; Daniel-Nava Rodruigues; Adriana C Flora; Patty Wai; Vidya Pawar; Simon McDade; Jason Carroll; Dominique Stoppa-Lyonnet; Andrew R Green; Ian O Ellis; Charles Swanton; Paul van Diest; Olivier Delattre; Christopher J Lord; William D Foulkes; Anne Vincent-Salomon; Alan Ashworth; Marc Henri Stern; Jorge S Reis-Filho
Journal:  J Pathol       Date:  2012-02-23       Impact factor: 7.996

View more
  93 in total

Review 1.  Towards precision medicine: from quantitative imaging to radiomics.

Authors:  U Rajendra Acharya; Yuki Hagiwara; Vidya K Sudarshan; Wai Yee Chan; Kwan Hoong Ng
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

Review 2.  Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics.

Authors:  Mayar Allam; Shuangyi Cai; Ahmet F Coskun
Journal:  NPJ Precis Oncol       Date:  2020-05-01

3.  Precision medicine with electronic medical records: from the patients and for the patients.

Authors:  Losiana Nayak; Indrani Ray; Rajat K De
Journal:  Ann Transl Med       Date:  2016-10

4.  Integration analysis of metabolites and single nucleotide polymorphisms improves the prediction of drug response of celecoxib.

Authors:  Xiaoqing Xing; Pengcheng Ma; Qing Huang; Xiemin Qi; Bingjie Zou; Jun Wei; Lei Tao; Lingjun Li; Guohua Zhou; Qinxin Song
Journal:  Metabolomics       Date:  2020-03-14       Impact factor: 4.290

Review 5.  Toward achieving precision health.

Authors:  Sanjiv Sam Gambhir; T Jessie Ge; Ophir Vermesh; Ryan Spitler
Journal:  Sci Transl Med       Date:  2018-02-28       Impact factor: 17.956

6.  A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma.

Authors:  Qunfeng Wu; Liya Pi; Thu Le Trinh; Chaohui Zuo; Man Xia; Yu Jiao; Zhouhua Hou; Sung Jo; William Puszyk; Kien Pham; David R Nelson; Keith Robertson; David Ostrov; Pranela Rameshwar; Chang Qing Xia; Chen Liu
Journal:  Mol Ther       Date:  2017-08-10       Impact factor: 11.454

7.  Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.

Authors:  Darue A Prieto; Donald J Johann; Bih-Rong Wei; Xiaoying Ye; King C Chan; Dwight V Nissley; R Mark Simpson; Deborah E Citrin; Crystal L Mackall; W Marston Linehan; Josip Blonder
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 8.  Turning omics data into therapeutic insights.

Authors:  Amanda Kedaigle; Ernest Fraenkel
Journal:  Curr Opin Pharmacol       Date:  2018-08-24       Impact factor: 5.547

Review 9.  Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical review.

Authors:  Irene Sarosiek; Rudolf Schicho; Pedro Blandon; Mohammad Bashashati
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

10.  Preappointment testing for BRAF/KIT mutation in advanced melanoma: a model in molecular data delivery for individualized medicine.

Authors:  Taofic Mounajjed; Char L Brown; Therese K Stern; Annette M Bjorheim; Andrew J Bridgeman; Kandelaria M Rumilla; Robert R McWilliams; Thomas J Flotte
Journal:  Hum Pathol       Date:  2014-07-30       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.